USP Comment Letter: Submitted to FDA on Biosimilars- Nonproprietary Naming of Biological Products" Draft Guidance for Industry (2015)

Submitted October 26, 2015 - USP Comment Letter to FDA on "Nonproprietary Naming of Biological Products" Draft Guidance for Industry" (Draft Guidance). Docket No. FDA-2013-D-1543

USP-Comments-to-FDA-on-Biosimilars-Comments.pdf (1.8 MB)